| [1] |
Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl)，2022，135(5)：584-590.
|
| [2] |
Lei S, Zheng R, Zhang S, et al. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020[J]. Cancer Commun (Lond)，2021，41(11)：1183-1194.
|
| [3] |
Warburg O. On respiratory impairment in cancer cells[J]. Science，1956，124(3215)：269-270.
|
| [4] |
Draoui N, Feron O. Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments[J]. Dis Model Mech，2011，4(6)：727-732.
|
| [5] |
Rizwan A, Serganova I, Khanin R, et al. Relationships between LDH-A, lactate, and metastases in 4T1 breast tumors[J]. Clin Cancer Res，2013，19(18)：5158-5169.
|
| [6] |
Naik A, Decock J. Lactate metabolism and immune modulation in breast cancer: a focused review on triple negative breast tumors[J]. Front Oncol，2020，10：598626.
|
| [7] |
Read JA, Winter VJ, Eszes CM, et al. Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase[J]. Proteins，2001，43(2)：175-185.
|
| [8] |
Kanno T, Sudo K, Kitamura M, et al. Lactate dehydrogenase A-subunit and B-subunit deficiencies: comparison of the physiological roles of LDH isozymes[J]. Isozymes Curr Top Biol Med Res，1983，7：131-150.
|
| [9] |
Everse J, Kaplan NO. Lactate dehydrogenases: structure and function[J]. Adv Enzymol Relat Areas Mol Biol，1973，37：61-133.
|
| [10] |
Tsujibo H, Tiano HF, Li SS. Nucleotide sequences of the cDNA and an intronless pseudogene for human lactate dehydrogenase-A isozyme[J]. Eur J Biochem，1985，147(1)：9-15.
|
| [11] |
Grosse F, Nasheuer HP, Scholtissek S, et al. Lactate dehydrogenase and glyceraldehyde-phosphate dehydrogenase are single-stranded DNA-binding proteins that affect the DNA-polymerase-alpha-primase complex[J]. Eur J Biochem，1986，160(3)：459-467.
|
| [12] |
Semenza GL, Jiang BH, Leung SW, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1[J]. J Biol Chem，1996，271(51)：32529-32537.
|
| [13] |
Shim H, Dolde C, Lewis BC, et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth[J]. Proc Natl Acad Sci U S A，1997，94(13)：6658-6663.
|
| [14] |
Li X, Qin C, Burghardt R, et al. Hormonal regulation of lactate dehydrogenase-A through activation of protein kinase C pathways in MCF-7 breast cancer cells[J]. Biochem Biophys Res Commun，2004，320(3)：625-634.
|
| [15] |
He L, Lv S, Ma X, et al. ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis[J]. Med Oncol，2022，39(4)：45.
|
| [16] |
Zhang L, Fu Y, Guo H. c-Myc-induced long non-coding RNA small nucleolar RNA host gene 7 regulates glycolysis in breast cancer[J]. J Breast Cancer，2019，22(4)：533-547.
|
| [17] |
Zhang L, Chen W, Liu S, et al. Targeting breast cancer stem cells[J]. Int J Biol Sci，2023，19(2)：552-570.
|
| [18] |
Chen C, Bai L, Cao F, et al. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis[J]. Oncogene，2019，38(23)：4527-4539.
|
| [19] |
Wang S, Ma L, Wang Z, et al. Lactate dehydrogenase-A (LDH-A) preserves cancer stemness and recruitment of tumor-associated macrophages to promote breast cancer progression[J]. Front Oncol，2021，11：654452.
|
| [20] |
Wang ZY, Loo TY, Shen JG, et al. LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis[J]. Breast Cancer Res Treat，2012，131(3)：791-800.
|
| [21] |
Arseneault R, Chien A, Newington JT, et al. Attenuation of LDHA expression in cancer cells leads to redox-dependent alterations in cytoskeletal structure and cell migration[J]. Cancer Lett，2013，338(2)：255-266.
|
| [22] |
Wu H, Wang Y, Ying M, et al. Lactate dehydrogenases amplify reactive oxygen species in cancer cells in response to oxidative stimuli[J]. Signal Transduct Target Ther，2021，6(1)：242.
|
| [23] |
Brooks GA. The science and translation of lactate shuttle theory[J]. Cell Metab，2018，27(4)：757-785.
|
| [24] |
Lin S, Sun L, Lyu X, et al. Lactate-activated macrophages induced aerobic glycolysis and epithelial-mesenchymal transition in breast cancer by regulation of CCL5-CCR5 axis: a positive metabolic feedback loop[J]. Oncotarget，2017，8(66)：110426-110443.
|
| [25] |
Brown TP, Ganapathy V. Lactate/GPR81 signaling and proton motive force in cancer: role in angiogenesis, immune escape, nutrition, and Warburg phenomenon[J]. Pharmacol Ther，2020，206：107451.
|
| [26] |
Mu X, Shi W, Xu Y, et al. Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer[J]. Cell Cycle，2018，17(4)：428-438.
|
| [27] |
Khajah MA, Khushaish S, Luqmani YA. Lactate dehydrogenase A or B knockdown reduces lactate production and inhibits breast cancer cell motility in vitro[J]. Front Pharmacol，2021，12：747001.
|
| [28] |
Apostolova P, Pearce EL. Lactic acid and lactate: revisiting the physiological roles in the tumor microenvironment[J]. Trends Immunol，2022，43(12)：969-977.
|
| [29] |
Gao J, Liang Y, Wang L. Shaping polarization of tumor-associated macrophages in cancer immunotherapy[J]. Front Immunol，2022，13：888713.
|
| [30] |
Santoni M, Romagnoli E, Saladino T, et al. Triple negative breast cancer: key role of tumor-associated macrophages in regulating the activity of anti-PD-1/PD-L1 agents[J]. Biochim Biophys Acta Rev Cancer，2018，1869(1)：78-84.
|
| [31] |
Chen P, Zuo H, Xiong H, et al. Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis[J]. Proc Natl Acad Sci U S A，2017，114(3)：580-585.
|
| [32] |
Lim SO, Li CW, Xia W, et al. EGFR signaling enhances aerobic glycolysis in triple-negative breast cancer cells to promote tumor growth and immune escape[J]. Cancer Res，2016，76(5)：1284-1296.
|
| [33] |
Erra DF, Ochoa V, Merlotti A, et al. Extracellular acidosis and mTOR inhibition drive the differentiation of human monocyte-derived dendritic cells[J]. Cell Rep，2020，31(5)：107613.
|
| [34] |
Long Y, Gao Z, Hu X, et al. Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma[J]. Cancer Med，2018，7(9)：4690-4700.
|
| [35] |
Xia C, Li M, Ran G, et al. Redox-responsive nanoassembly restrained myeloid-derived suppressor cells recruitment through autophagy-involved lactate dehydrogenase A silencing for enhanced cancer immunochemotherapy[J]. J Control Release，2021，335：557-574.
|
| [36] |
Kumagai S, Koyama S, Itahashi K, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments[J]. Cancer Cell，2022，40(2)：201-218.
|
| [37] |
Liu J, Zhang C, Zhang T, et al. Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer[J]. Nat Metab，2022，4(12)：1830-1846.
|
| [38] |
Wan L, Pantel K, Kang Y. Tumor metastasis: moving new biological insights into the clinic[J]. Nat Med，2013，19(11)：1450-1464.
|
| [39] |
Talaiezadeh A, Shahriari A, Tabandeh MR, et al. Kinetic characterization of lactate dehydrogenase in normal and malignant human breast tissues[J]. Cancer Cell Int，2015，15：19.
|
| [40] |
Mehdi M, Menon M, Seyoum N, et al. Blood and tissue enzymatic activities of GDH and LDH, index of glutathione, and oxidative stress among breast cancer patients attending referral hospitals of addis ababa, ethiopia: hospital-based comparative cross-sectional study[J]. Oxid Med Cell Longev，2018，2018：6039453.
|
| [41] |
Brown JE, Cook RJ, Lipton A, et al. Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer: a retrospective analysis in bisphosphonate-treated patients[J]. Clin Cancer Res，2012，18(22)：6348-6355.
|
| [42] |
Liu D, Wang D, Wu C, et al. Prognostic significance of serum lactate dehydrogenase in patients with breast cancer: a meta-analysis[J]. Cancer Manag Res，2019，11：3611-3619.
|
| [43] |
Ma YY, Wang H, Zhao WD, et al. Prognostic value of combined lactate dehydrogenase, C-reactive protein, cancer antigen 153 and cancer antigen 125 in metastatic breast cancer[J]. Cancer Control，2022，29：1399496098.
|
| [44] |
Terpos E, Katodritou E, Roussou M, et al. High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents[J]. Eur J Haematol，2010，85(2)：114-119.
|
| [45] |
Chen B, Dai D, Tang H, et al. Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer[J]. J Cancer，2016，7(15)：2309-2316.
|
| [46] |
Pelizzari G, Basile D, Zago S, et al. Lactate dehydrogenase (LDH) response to first-line treatment predicts survival in metastatic breast cancer: first clues for a cost-effective and dynamic biomarker[J]. Cancers (Basel)，2019，11(9)：1243.
|
| [47] |
Xiao X, Huang X, Ye F, et al. The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer[J]. Sci Rep，2016，6：21735.
|
| [48] |
Dong T, Liu Z, Xuan Q, et al. Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis[J]. Sci Rep，2017，7(1)：6069.
|
| [49] |
Liu X, Meng QH, Ye Y, et al. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer[J]. Carcinogenesis，2015，36(2)：243-248.
|
| [50] |
Robain M, Pierga JY, Jouve M, et al. Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer[J]. Eur J Cancer，2000，36(18)：2301-2312.
|
| [51] |
Jia Z, Zhang J, Wang Z, et al. An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer[J]. Oncotarget，2018，9(12)：10714-10722.
|
| [52] |
Zhou M, Zhao Y, Ding Y, et al. Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol[J]. Mol Cancer，2010，9：33.
|
| [53] |
Govoni M, Rossi V, Di Stefano G, et al. Lactate upregulates the expression of DNA repair genes, causing intrinsic resistance of cancer cells to cisplatin[J]. Pathol Oncol Res，2021，27：1609951.
|
| [54] |
Das CK, Parekh A, Parida PK, et al. Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer[J]. Biochim Biophys Acta Mol Cell Res，2019，1866(6)：1004-1018.
|
| [55] |
Chen X, Luo R, Zhang Y, et al. Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer[J]. Nat Commun，2022，13(1)：7160.
|
| [56] |
Zhao Y, Liu H, Liu Z, et al. Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism[J]. Cancer Res，2011，71(13)：4585-4597.
|
| [57] |
Yang T, Fu Z, Zhang Y, et al. Serum proteomics analysis of candidate predictive biomarker panel for the diagnosis of trastuzumab-based therapy resistant breast cancer[J]. Biomed Pharmacother，2020，129：110465.
|
| [58] |
Li L, Ai L, Jia L, et al. High score of LDH plus dNLR predicts poor survival in patients with HER2-positive advanced breast cancer treated with trastuzumab emtansine[J]. BMC Cancer，2022，22(1)：29.
|
| [59] |
Koukourakis MI, Kakouratos C, Kalamida D, et al. Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer[J]. Int J Radiat Biol，2016，92(7)：353-363.
|
| [60] |
Schwab M, Thunborg K, Azimzadeh O, et al. Targeting cancer metabolism breaks radioresistance by impairing the stress response[J]. Cancers (Basel)，2021，13(15).
|
| [61] |
Zhao Y, Zhong R, Deng C, et al. Circle RNA circABCB10 modulates PFN2 to promote breast cancer progression, as well as aggravate radioresistance through facilitating glycolytic metabolism via miR-223-3p[J]. Cancer Biother Radiopharm，2021，36(6)：477-490.
|